Fundación para la Investigación del Hospital Clínico de Valencia clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
4 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 2 with minor changes only.
- Notable: SHort Of Pace - Heart Failure (SHOP-HF) Primary and study completion pushed from Jun 2026 to Jun 2027
-
Minor: 2 trials marked Unknown by the registry's verification sweep Changed
- Minor: TRAIN-SARC · Exercise Program in Women Over 60 yr. With HFpEF and Sarcopenia on Functional Capacity and Quality of Life Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Minor: Train-CR · Supervised Training Program on Functional Capacity · HF and Cardiorenal Syndrome Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Notable: Virtual Reality Intervention to Improve Comfort in Hospitalized Hematology Patients Recruitment opened
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-26 | NCT07894601 Virtual Reality Intervention to Improve Comfort in Hospitalized Hematology Patients | Recruiting |
Active trials by phase
| Phase 2 | 1 | |
| Phase 3 | 3 | |
| Phase 4 | 2 |
Not charted: 12 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 11
Heart Disease (7) · Heart Failure (4) · Breast Cancer (2) · Chronic Kidney Disease (2) · Colorectal Cancer (2) · Coronary Artery Disease (1) · Diabetes (1) · Gastric Cancer (1) · HER2-Positive Cancer (1) · Pancreatic Cancer (1)
Get alerts when Fundación para la Investigación del Hospital Clínico de Valencia's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.